Hypoglycemia Fear and Psychological Resilience: Effects on Disease Acceptance in Type II Diabetes

Aim: This study aimed to evaluate the effects of fear of hypoglycemia and psychological resilience on disease acceptance and action in individuals with type II diabetes. Methods: This research was conducted as a cross-sectional study online from January 1 to June 30, 2023, involving 105 participants. Data were collected using a Personal Information Form, the Fear of Hypoglycemia Scale (FOH), the Brief Resilience Scale (BRS), and the Acceptance and Action Diabetes Questionnaire (AADQ). Ethical approval was obtained for the study. Results: The mean age of participants was 49.71±16.21 years, with 53.3% being female. Among the participants, 49.5% used oral diabetic medications, 67.6% had regular medical checkups, and 54.3% had at least one additional chronic condition. Neuropathy was reported by 24.8% of the participants. The mean scores were: FOH 27.93±22.16, BRS 16.63±4.14, and AADQ 45.21±10.98. Multiple regression analysis indicated that factors such as income being less than expenses (p=0.064), regular doctor checkups (p=0.001), and worries about hypoglycemia (p=0.001) predicted 22.6% of the variance in AADQ scores. Conclusion: The study found a weak, negative relationship between fear of hypoglycemia, psychological resilience, and disease acceptance in individuals with type II diabetes. These findings underscore the need to assess psychological factors during routine checkups to enhance disease management.